MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • MDS Virtual Congress 2020

    Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study Update

    N. Dissanayaka, G. Byrne, L. Mitchell, J. O'Sullivan, A. Padmassini, E. White, J. Yang, E. Forbes, K. Thangavelu, T. Au, A. Lehn, R. Adam, N. Pachana (Brisbane, Australia)

    Objective: 1. To develop an inventory to assess Parkinson’s disease (PD) specific anxiety for person centred psychotherapy interventions. 2. To develop manualised cognitive behaviour therapy…
  • MDS Virtual Congress 2020

    The Efficacy of Teleconsultation for Management of Movement Disorders in Thailand

    W. Phuenpathom, P. Jagota, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate the efficacy of movement disorders teleconsultation in Thailand. Background: Though movement disorders are common, there are relatively small numbers of movement disorders…
  • MDS Virtual Congress 2020

    Using mindfulness to improve self-awareness in Parkinson’s disease patients – preliminary results of a randomized controlled trial

    T. Buchwitz, F. Maier, A. Greuel, C. Eggers (Marburg, Germany)

    Objective: This clinical trial aims to investigate the effects and feasibility of a newly developed 8-week mindfulness intervention on self-awareness in Parkinson’s disease (PD) patients.…
  • MDS Virtual Congress 2020

    Cardiovascular Fitness, Plasma Biomarkers and Dopaminergic Denervation in Parkinson’s Disease

    J. Morley, J. Dubroff, G. Cheng, B. Taylor, S. Wood, J. Duda (Philadelphia, PA, USA)

    Objective: To examine the relationship between cardiovascular (CV) fitness, plasma biomarkers associated with PD progression and/or exercise and dopaminergic denervation, measured by I-123-Ioflupane single photon…
  • MDS Virtual Congress 2020

    The Cognitive Training In Parkinson Study (COGTIPS), a randomized controlled trial

    T. van Balkom, H. Berendse, Y. v.d. Werf, J. Twisk, R. Hagen, T. Berk, O. v.d. Heuvel, C. Vriend (Amsterdam, Netherlands)

    Objective: In this randomized controlled trial [1], our objective was to assess the effect of online home-based cognitive training on objective cognitive functioning and subjective…
  • MDS Virtual Congress 2020

    Non-pharmacological Treatment for Parkinson’s Disease Patients with Depression: A Meta-analysis of Repetitive Transcranial Magnetic Stimulation and Cognitive-Behavioral Treatment

    J.N Chen, P.K He, Y.H Zhang, YY. Gao, Y.H Qiu, Y. Li, Q.X Zhang, L.M Wang, J.H Zhao, K. Nie, L.J Wang (Guangzhou, China)

    Objective: This meta-analysis aims to assess the effect of non-pharmacological treatments for depression in patients with PD. Background: Antidepressants are the mainstay of treatment for…
  • MDS Virtual Congress 2020

    Novel walker attachment for gait dysfunction in Parkinson’s disease: Case report

    C. Gill, P. Schmitt, J. Karl, L. Verhagen Metman (Chicago, IL, USA)

    Objective: To describe a patient with advanced PD who noted improved balance and fewer falls while using a novel belt attachment for his assistive device.…
  • MDS Virtual Congress 2020

    Improving person – centered healthcare pathway organization for people with Parkinson’s disease, using Article 51.

    S. Bayen, C. Moreau, N. Carrière, JP. Pruvo, M. Bayen, F. Richard, B. Dervaux, L. Defebvre, D. Devos (Lille, France)

    Objective: To optimize efficacy and efficiency of the healthcare pathway (HCPW) for people with Parkinson’s disease (PwPD), using the political framework Article 51. Background: Parkinson’s…
  • MDS Virtual Congress 2020

    Ceftriaxone improves motor function in a rat hemi-parkinsonian model: Potential to delay bilateral progression of motor deficits in Parkinson’s disease

    E. Kasanga, C. McElroy, M. Salvatore (Fort Worth, TX, USA)

    Objective: This study sought to evaluate the impact of ceftriaxone, as a potential repurposed drug, in ameliorating motor decline in a unilateral rat 6-hydroxydopamine (6-OHDA)…
  • 2019 International Congress

    Kick Out PD: Mobility, Quality of Life, and Feasibility Outcomes in a Pilot Study of a PD-Specific Karate Intervention

    B. Sennott, C. Niemet, M. Lee, C. Whitelock, M. Sanghvi, Y. Liu, J. Chodosh, D. Hall, C. Comella, J. Fleisher (Chicago, IL, USA)

    Objective: To evaluate feasibility of a community-based karate class tailored for individuals with early- to middle-stage Parkinson’s Disease (PD); to assess effect of karate on…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #29077 (not found)
  • #29056 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28189 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley